Self-trephining implant and methods thereof for treatment of ocular disorders

• US 8,062,244 B2
• Filed: 02/05/2009
• Issued: 11/22/2011
• Est. Priority Date: 04/07/2001
• Status: Expired due to Term

• Current Assignee: Glaukos Corporation
• Original Assignee: Glaukos Corporation
• Inventors: Niksch, Barbara A, Tu, Hosheng, Haffner, David, Smedley, Gregory T
• Primary Examiner(s): Deak; Leslie R
• Application Number:
  US12/366,508
• Publication Number:
  US 20090143712A1
• Time in Patent Office: 1,020 Days
• Field of Search: 604/8, 604/9, 604/264, 623/4.1, 623/6.12
• US Class Current: 604/8
• CPC Class Codes: A61F 9/00781 Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment drainage implants in general A61M27/002
• CPC Class Codes: A61M 27/00 Drainage appliance for wounds or the like , i.e. wound drains, implanted drains negative pressure wound therapy devices A61M1/90; implements for holding wound open A61B17/02 ; middle ear drainage A61F11/202

Abstract

Implants and methods for treating ocular disorders are disclosed. One implant has a tubular member, with inlet and outlet ends, and a cutting member connected thereto. The tubular member is configured to extend through eye tissue such that the inlet and outlet ends reside respectively in an anterior chamber and a physiologic outflow pathway of the eye. Desirably, the cutting member is configured to make an incision in the eye tissue for receiving at least a portion of the tubular member. One method involves introducing an implant, with proximal and distal ends, into the anterior chamber and penetrating eye tissue using an implant distal portion. The implant is advanced from the anterior chamber into the penetrated eye tissue to locate the distal and proximal ends respectively in the physiologic outflow pathway and the anterior chamber. Aqueous humor is conducted between the proximal and distal ends.

Claims

1. A method of treating an ocular disorder, comprising:

providing an ocular drainage implant having a proximal end and a distal section with a distal end;

forming a first opening to access an anterior chamber of an eye of a mammal;

advancing the ocular drainage implant through the first opening and into the anterior chamber of the eye, said ocular drainage implant having a maximum cross-sectional dimension sized to fit through the first opening;

transporting the ocular drainage implant through at least a portion of the anterior chamber with the distal end of the ocular drainage implant leading the proximal end of the ocular drainage implant and positioning at least the distal end of the ocular drainage implant within an anterior chamber angle of the eye;

forming, from within the anterior chamber, a second opening in eye tissue in the anterior chamber angle using the distal end of the ocular drainage implant; and

advancing the distal end of the ocular drainage implant through the second opening such that at least a portion of the distal section of the ocular drainage implant extends into and along a portion of a physiologic outflow pathway.

2. The method of claim 1, wherein forming a second opening and advancing the ocular drainage implant through the second opening occur concurrently.

3. The method of claim 2, wherein forming the second opening comprises passing the distal end of the ocular drainage implant through a trabecular meshwork of the eye to position the distal end into Schlemm'"'"'s canal of the eye.

4. The method of claim 2, wherein advancing the ocular drainage implant into the anterior chamber involves positioning the entire ocular drainage implant in the anterior chamber before advancing the implant into ocular tissue through the second opening.

5. The method of claim 2, wherein advancing the ocular drainage implant into the anterior chamber involves positioning both the proximal and distal ends of the ocular drainage implant in the anterior chamber.

6. The method of claim 5, wherein the proximal end of the ocular drainage implant is introduced into the anterior chamber before the distal end segment is inserted into ocular tissue.

7. The method of claim 2, wherein the first opening is made to be self-sealing.

8. The method of claim 2, wherein the first opening is made no larger than about 1 mm.

9. The method of claim 2, wherein the advancing the ocular drainage implant comprises positioning at least a portion of the ocular drainage implant so as to be in contact with a choroid of the eye.

10. The method of claim 9, wherein the distal end is positioned so as to be in contact with the choroid.

11. The method of claim 9, wherein positioning at least a portion of the ocular drainage implant in contact with the choroid further comprises placing the portion of the ocular drainage implant to contact ciliary tissue of the eye.

12. The method of claim 2, wherein the distal end of the implant is located in Schlemm'"'"'s canal.

13. The method of claim 2, wherein the distal end of the implant is located in a collector duct.

14. The method of claim 2, wherein advancing involves placing the distal end of the ocular drainage implant so as to drain into a segment of the uveoscleral outflow pathway.

15. A method of treating an ocular disorder, comprising:

providing an ocular drainage implant having a proximal end and a distal section with a distal end;

forming a first opening to access an anterior chamber of an eye of a mammal;

advancing the ocular drainage implant through the first opening and into the anterior chamber of the eye, said ocular drainage implant having a maximum cross-sectional dimension sized to fit through the first opening;

transporting the ocular drainage implant through at least a portion of the anterior chamber with the distal end of the ocular drainage implant leading the proximal end of the ocular drainage implant and positioning at least the distal end of the ocular drainage implant within an anterior chamber angle of the eye; and

advancing the distal end of the ocular drainage implant through an opening in eye tissue in the anterior chamber angle formed using the distal end of the ocular drainage implant such that at least a portion of the distal section of the ocular drainage implant extends into and along a portion of the uveal scleral outflow pathway so as to be in contact with a choroid of the eye.

16. The method of claim 15, wherein advancing the ocular drainage implant through the first opening into the anterior chamber involves positioning the entire ocular drainage implant in the anterior chamber before advancing the distal end of the ocular drainage implant into tissue in the anterior chamber angle.

17. The method of claim 15, wherein advancing the ocular drainage implant into the anterior chamber involves positioning both the proximal and distal ends of the ocular drainage implant in the anterior chamber.

18. The method of claim 17, wherein the proximal end of the ocular drainage implant is introduced into the anterior chamber before the distal end is inserted into ocular tissue.

19. The method of claim 15, wherein the first opening is made to be self-sealing.

20. The method of claim 15, wherein the first opening is made no larger than about 1 mm.